Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Impressive Q2 Performance Drives Further Guidance Raise At ANI
Firm Now Anticipates 2023 Net Revenue Between $425m And $445m
Aug 22 2023
•
By
Chloe Kent
ANI's performance was driven by generic products and Cortrophin gel • Source: Shutterstock
More from Earnings
More from Business